BiotechTube
Home/Alector/Neil Berkley, M.S., M.B.A.
NB

Neil Berkley, M.S., M.B.A.

Chief Financial Officer and Chief Business Officer

Alector

Therapeutic Areas

Neurodegenerative DiseasesNeurologyImmunology

Alector Pipeline

DrugIndicationPhase
AL001 (latozinemab)Frontotemporal Dementia with progranulin mutation (FTD-GRN)Phase 3
AL101 / GSK4527226Early Alzheimer's DiseasePhase 2
AL002Early Alzheimer's DiseasePhase 2
AL001Frontotemporal Dementia with C9orf72 mutation (FTD-C9)Phase 2
AL008Oncology (Various Cancers)Preclinical

Leadership Team at Alector

AR
Arnon Rosenthal, Ph.D.
Co-Founder, Chief Executive Officer, and Director
GS
Giacomo Salvadore, M.D.
Chief Medical Officer
View full Alector profile